NEJM Journal Watch Coverage of COVID-19

We present new summaries, commentary, and news on the pandemic.

Dear readers,

Recently NEJM Journal Watch covered COVID-19–related topics including mortality after ECMO, SARS-CoV-2 vaccine responses in patients receiving MS treatment, durability of vaccine-induced immunity, azithromycin for COVID-19 outpatients, and the casirivimab and imdevimab cocktail.

This information appears on the NEJM Journal Watch COVID-19 page (https://www.jwatch.org/covid-19) and on the New England Journal of Medicine coronavirus site (https://www.nejm.org/coronavirus).

As always, we continue to provide our regular coverage of other important infectious diseases research.

Author

Richard T. Ellison III, MD

Disclosures

Consult/Advisory BoardAcurx Pharmaceuticals, LLC;

Grant/Research SupportDoctors Company Foundation, Massachusetts Department of Public Health

Richard T. Ellison III, MD

Disclosures

Consult/Advisory BoardAcurx Pharmaceuticals, LLC;

Grant/Research SupportDoctors Company Foundation, Massachusetts Department of Public Health

NEJM Journal Watch Coverage of COVID-19

Topics

Author